The Future of Mass Spectrometry

This event is now available on demand.




Event Overview:

Join us for this virtual symposium as we explore the future of mass spectrometry (MS) technology. Technical talks from scientists at leading mass spectrometry instrument manufacturers will bring you up to date on important developments. They will explain and demonstrate the technologies underlying advanced capabilities of mass spectrometry techniques and instruments, addressing how those capabilities can translate into performance improvements such as increased sensitivity, greater robustness, and ease-of-use. They will also describe advances in practical applications of mass spectrometry techniques, illustrating the work with real examples and data. You will be able to ask all your questions, too. Are you missing the opportunity to explore new products hands-on at a live event? Are you finding online videos too brief, and craving the opportunity to ask your specific questions? This event will give you the answers you seek. Sign up today!  

Key Objectives:
  • Get up to speed on the latest in mass spectrometry technology
  • Understand where mass spectrometry tools are heading
  • Gain practical information to make your work easier and more effective


Agenda

Morning session: 9:00 a.m.–12:00 p.m. EDT
9:00 a.m. EDT    IDEX Health & Science Automating Mass Spec Workflows for Bioprocessing PAT
Craig Love, Principal Scientist, Research and Development, Graham Shelver, Lead Application Scientist, Engineering, Quan Liu, Principal Engineer, Research and Development
                             IDEX Health & Science bridging the gap between the cell culture process and analytical instrumentation at all scales from R&D to manufacturing. The lack of real time CQA/CPP data from cell culture process is a pain point that adds time and complexity to biotherapeutic drug development.  Our expertise enables simplification of workflows related to characterizing biotherapeutic molecules and their production processes analytical instruments (Sciex triple quad 6500 plus, 7500, and the 7600 ZenoTOF) and the performance was compared.

9:20 a.m. EDT   Innovations in MS deliver robust quantitation to obtain high sensitivity results from the most challenging matrices and sample types.
Ian Moore, Senior Technical Product Manager, SCIEX
Promise more from your time. Increased uptime, improved serviceability and automated decision making means your triple quad mass spectrometer spends more time generating the results you need to hit your project deadlines. Join us to explore a system that works as hard as you do in high stakes situations.

9:40 a.m. EDT           Upgrade your protein characterization game with Agilent ExD
Christian Klein, PhD, Product Manager LC/Q-TOF, Joseph Meeuwsen, PhD, Product Manager ExD
Agilent Technologies, Inc.
 
Experienced biopharma scientists who specialize in peptide and protein characterization face increasing pressure to achieve in-depth characterization with streamlined workflows, ensuring precise data and timely results.  The Agilent ExD cell, now available for the Agilent 6545XT AdvanceBio LC/QTOF, adds electron capture dissociation (ECD), to the existing capabilities of the 6545XT system, elevating peptide and protein analyses to the next level  and enabling time saving new approaches.

 



Featured Speakers:

Craig Love
Craig Love
Principal Scientist of Research & Development
IDEX Health & Science

Craig Love is a Principal Scientist of Research & Development supporting customers in the development and optimization of fluidic subsystems for sample preparation, process analytics, and mass spectrometry. Craig has over 25 years of experience with analytical instrumentation characterizing a wide range of small molecule and biological sample types. He has also been involved with the development of several commercial LC/MS instruments. Craig holds a Master’s Degree in Chemistry from the University of Oregon.

Graham Shelver
Graham Shelver
Senior Applications Scientist
IDEX Health & Science

Graham Shelver is a Senior Applications Scientist, supporting IDEX Health & Science engineering teams developing novel fluidic technologies for the biopharmaceutical industry. Graham has 30 years of experience with isolation, purification, and analysis in pharmaceuticals, biopharmaceuticals, and hydrocarbon processing. Graham obtained a Master’s Degree from the University of Natal and a PhD from the University of the Witwatersrand.

Quan Liu
Quan Liu
Principal Engineer of Research & Development team
IDEX Health & Science

Quan Liu is a Principal Engineer of Research & Development team, supporting development and optimization of fluidic system for various applications.  Quan has been with IDEX Health & Science for 18 years and has extensive experiences incorporating different fluidic components to solve customer’s fluidic needs.  Quan holds a Ph.D. Degree in Chemical Engineering from Tulane University.

Ian Moore
Ian Moore
Senior Technical Product Manager
SCIEX
Ian Moore is a Senior Technical Product Manager for the nominal mass product line at SCIEX. He has held roles like Application Scientist and Technical Marketing manager, and more recently has been part of the product management team that has launched products like the SCIEX Triple Quad 5500+ and the SCIEX 7500 systems. Prior to joining SCIEX Ian worked for 7 years in the pharmaceutical industry as Lead Analytical Scientist and Senior Scientist. Ian holds a PhD in Chemistry from The University of Toronto.

Christian Klein, PhD
Christian Klein, PhD
Product Manager LC/Q-TOF
Agilent Technologies, Inc.

With an education in chemistry, Chris Klein received his PhD in 2005 at the Max Planck Institute for Biochemistry in Martinsried, Germany, working on membrane proteins and mass spectrometry. After a post doctorate and three years as demo chemist and product specialist with Bruker Daltonics, Chris joined the Agilent LC/Q-TOF R&D team in 2010. Since 2018, he has been the LC/Q-TOF and IM-QTOF product manager.

Joseph Meeuwsen, PhD
Joseph Meeuwsen, PhD
Product Manager ExD
Agilent Technologies, Inc.

Dr. Joseph Meeuwsen is the product manager for ExD technologies at Agilent. He completed his PhD in molecular and cellular biology at Oregon State University (OSU) in 2020. During his PhD, he started working at e-MSion, Inc., a company started in 2015 by OSU researchers to develop the ExD cell platform into a commercial product. His initial role as an applications scientist expanded to include diverse responsibilities in the areas of support, sales, marketing, and R&D. He became product manager for the ExD cell in 2021 and continued this role when Agilent acquired e-MSion in 2023.




For any technical questions please contact Jordan Ramesh: jramesh@mjhlifesciences.com